GoldenGolden
PreciThera

PreciThera

PreciThera, Inc. is a biotech company that is positioned to develop therapies for bone diseases.

PreciThera, Inc. is a biotech company that is positioned to develop therapies for bone diseases, leveraging the application of computational technology and disease pathology. It focuses on diverse genetic disorders that appears in bone dysfunction.

Timeline

July 27, 2017
PreciThera raises a $29,000,000 series A round from Sanderling.
July 2017
PreciThera raises a $29,000,000 series A round from Arix Bioscience plc, CTI Life Sciences Fund, Emerillon Capital, Fonds de solidarité FTQ and Sanderling Ventures.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.